Diabetes Mellitus, Type 1: all 3,614 studies
Page 25 of 37. Open to participants first (586), then studies with results posted, then the rest; newest registration first within each.
- Brown Adipose Tissue in Type 1 DiabetesCompletedNCT02984514Not applicable
- iOmit: Reducing Intentional Insulin Misuse in Type 1 DiabetesCompletedNCT02980627Not applicable
- Family Routines Enhancing Adolescent Diabetes by Optimizing ManagementCompletedNCT02974309Not applicable
- A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.ConnectCompletedNCT02970656Not applicable
- Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 DiabetesCompletedNCT02970357Not applicable
- Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes MellitusStatus unknownNCT02953249
- Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose MonitoringCompletedNCT02942069
- Hypoglycaemia Awareness Restoration ProgrammeCompletedNCT02940873Not applicable
- Use of Stem Cells in Diabetes Mellitus Type 1Status unknownNCT02940418Phase 1
- Impact of Different Types of Exercise Training on Biochemical Markers of Insulin-dependent PatientsCompletedNCT02939768Not applicable
- One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™CompletedNCT02939118
- The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in ChildrenCompletedNCT02938806
- A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes MellitusCompletedNCT02938572Phase 1
- Periodontal and Salivary Evaluation of Type 1 Diabetes Mellitus PatientsCompletedNCT02935868
- Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic PatientsCompletedNCT02929953
- Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 DiabetesCompletedNCT02928250Not applicable
- Effectiveness of Carbohydrate Counting Method With Mixed MealsCompletedNCT02928016Not applicable
- Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in HealthyActive, not recruitingNCT02923323Not applicable
- Measuring and Predicting Glycemic Response to Food in Patients With Type 1 DiabetesStatus unknownNCT02919839
- ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed GlucagonCompletedNCT02916251Phase 2
- Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)CompletedNCT02914886Phase 4
- ACT Stress Management in Type 1 DiabetesActive, not recruitingNCT02914496Not applicable
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCompletedNCT02910518Phase 1
- Clinical Features and Prevalence of Asymptomatic Peripheral Artery Disease in Patients With Type 1 Diabetes MellitusCompletedNCT02910271
- Safety and Efficacy of Artificial Pancreas With and Without a Meal Detection Module on Glycemic Control in Adolescents With Type 1 Diabetes After a Missed BolusCompletedNCT02909829Not applicable
- Sleep, Coping and Executive Functioning in Youth With Type 1 DiabetesCompletedNCT02908555
- Incretin-based Therapy in Early Diagnosed Type 1 DiabetesCompletedNCT02908087Phase 2
- A Reinforcement Approach to Increase Use of CGMCompletedNCT02907346Not applicable
- A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management CompanionTerminatedNCT02906891Not applicable
- Incretin-based Therapy in Late Preclinical Type 1 DiabetesCompletedNCT02898506Phase 2
- Insulet Artificial Pancreas Early Feasibility StudyCompletedNCT02897557Not applicable
- A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes MellitusCompletedNCT02897219Phase 3
- MSC Administration for the Management of Type 1 Diabetic PatientsStatus unknownNCT02893306Phase 2
- Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 DiabetesTerminatedNCT02892604Not applicable
- Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting InstructionsStatus unknownNCT02888951
- Effects of Web-Based Health Information on Risk Behavior for Youth With Type 1 Diabetes in CollegeCompletedNCT02883829Not applicable
- The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes MellitusCompletedNCT02882737Not applicable
- Autoimmune Diabetes Accelerator Prevention TrialWithdrawnNCT02881528Phase 4
- The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 DiabetesCompletedNCT02881060Phase 4
- Psychosocial Functioning in Young Adults With Type 1 DiabetesCompletedNCT02874612
- Late Night Snack and Insulin GlargineCompletedNCT02871180Not applicable
- Closed Loop From Onset in Type 1 DiabetesActive, not recruitingNCT02871089Not applicable
- Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL FunctionCompletedNCT02862860Not applicable
- Mobile Technology & Online Tools to Track Adherence in Chronic Illness PatientsCompletedNCT02861157Phase 2
- Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 DiabetesCompletedNCT02860611
- Needs Assessment of Mediterranean Adolescents With Type 1 Diabetes About Therapeutic Education SessionsCompletedNCT02859779Not applicable
- Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 DiabetesCompletedNCT02855307Phase 2
- Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 DiabetesStatus unknownNCT02854696Phase 3
- Bigfoot Biomedical Clinical Research Center (CRC) TrialCompletedNCT02849288Phase 1
- Remote Monitoring of Diabetes in Young Children With Type 1 DiabetesCompletedNCT02848261Not applicable
- Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 DiabetesWithdrawnNCT02846857Phase 2
- Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 DiabetesCompletedNCT02846831Phase 2
- International Diabetes Closed Loop (iDCL) Trial: Research Site Training ProtocolCompletedNCT02844517Not applicable
- Factors in Accuracy Studies Influencing Measured CGM Performance.CompletedNCT02843503Not applicable
- Type One Diabetes and Low Carb StudyCompletedNCT02839174
- Cognitive-Behavioral Therapy (CBT) in Children With DiabetesTerminatedNCT02839031Not applicable
- Enhanced Epidermal Antigen Specific Immunotherapy Trial -1CompletedNCT02837094Phase 1
- Evaluation of iDECIDE: A Smartphone App for Insulin Dosing Accounting for Alcohol and ExerciseWithdrawnNCT02835183Not applicable
- Mental Health Screenings in Adolescents With Type I DiabetesCompletedNCT02835014
- Microalbuminuria and Allopurinol in Type 1 DiabetesCompletedNCT02829177Phase 4
- Evaluation of Glycemic Changes During Exercise in Children With Type 1 DiabetesCompletedNCT02824510Not applicable
- Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic SyndromeCompletedNCT02821585Not applicable
- Omental Islet TransplantCompletedNCT02821026Phase 1/2
- Neuropeptide Therapy of Recent Onset Type 1 DiabetesStatus unknownNCT02820558Phase 1
- Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 DiabetesCompletedNCT02814123Phase 2
- Teleconsultation in Type 1 Diabetes MellitusCompletedNCT02812498Not applicable
- Let's Empower and Prepare Young Adults With Type 1 DiabetesCompletedNCT02807155Not applicable
- Gene-virus Interactions Implicated in Type 1 DiabetesWithdrawnNCT02804165Not applicable
- Islet Transplant Alone in OMENtumActive, not recruitingNCT02803905Phase 2
- Monotherapy With Rapamycin in Long-standing Type 1 DiabetesCompletedNCT02803892Phase 2
- Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2CompletedNCT02798250Phase 2
- Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home)CompletedNCT02796534
- STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide StudyCompletedNCT02796248
- Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)CompletedNCT02794155Phase 2
- Patient With Any Pathology (According to the Appreciation of the Investigator) Which Could Disturb the Participation in the StudyStatus unknownNCT02793427Not applicable
- Creative Arts Diabetes Initiative for Youth/Young Adults Transitioning to Adult CareCompletedNCT02790892Not applicable
- Telemedicine Program in Type 1 Diabetes and CSIICompletedNCT02790645Not applicable
- Fear of Hypoglycemia and Glycemic VariabilityCompletedNCT02790060
- INTEGRATED IMPACT ASSESSMENT a Telemedicine Program in the Care of Patients With Diabetes Mellitus Type 1 Intensive Treatment With Multiple Daily Injections.CompletedNCT02784236Not applicable
- Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 DiabetesCompletedNCT02782195
- Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2CompletedNCT02776696Not applicable
- Patients Perceptions of Using the "Libre" System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat TrialCompletedNCT02776007Not applicable
- Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 DiabetesCompletedNCT02774876Phase 2
- Fault Detection, Zone MPC and DiAs System in T1DStatus unknownNCT02773875Not applicable
- T1DM Immunotherapy Using Polyclonal Tregs + IL-2CompletedNCT02772679Phase 1
- MMPPC Outpatient Clinical Protocol 2016CompletedNCT02769884Phase 2
- Bright 1 Bodies Weight Management ProgramCompletedNCT02768987Not applicable
- The Effects of Metformin on Glycemic Control and Insulin Sensitivity in Adolescents With T1DMCompletedNCT02765347Phase 4
- Reducing Stress in Adolescents and Young Adults With Type 1 Diabetes to Improve Diabetes CareCompletedNCT02760303Not applicable
- Glucose Variability in Patients With Type 1 Diabetes With a Sucrose-added DietCompletedNCT02758483Not applicable
- Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes MellitusCompletedNCT02755064Phase 1
- Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, GermanyCompletedNCT02750527
- Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 DiabetesStatus unknownNCT02750111
- Cerebral Responses to Insulin Induced HypoglycemiaCompletedNCT02747680Not applicable
- Analysis of B Cells From Autoimmune IndividualsCompletedNCT02747277
- Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With DiabetesStatus unknownNCT02745808Phase 1
- A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DMCompletedNCT02739906Phase 1/2
- Exenatide and Impaired Hypoglycaemic Awareness in Type 1 DiabetesCompletedNCT02735031Phase 2/3
- Accuracy of Freestyle LibreStatus unknownNCT02734745Not applicable
- Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 DiabetesWithdrawnNCT02733211Not applicable